Abstract
This study assessed whether behavioral differences explained higher human immunodeficiency virus (HIV) seroprevalence among injection drug users (IDUs) in three East Coast versus two West Coast cities in the United States. Sociodemographic, sexual, and injecting information were collected during semiannual face-to-face interviews. Baseline data from New York City; Baltimore, Maryland; and New Haven, Connecticut, were compared with data from Los Angeles, California, and San Jose, California. Among 1,528 East Coast and 1,149 West Coast participants, HIV seroprevalence was 21.5% and 2.3%, respectively (odds ratio [OR] 11.9; 95% confidence interval [CI] 7.9–17.8). HIV risk behaviors were common among IDUs on both coasts, and several were more common among West Coast participants. Adjusting for potential risk factors, East (vs. West) Coast of residence remained highly associated with HIV status (adjusted OR 12.14; 95% CI 7.36–20.00). Differences in HIV seroprevalence between East and West Coast cities did not reflect self-reported injection or sexual risk behavior differences. This suggests that other factors must be considered, such as the probability of having HIV-infected injection or sexual partners. Prevention efforts are needed on the West Coast to decrease HIV-associated risk behaviors among IDUs, and further efforts are also needed to reduce HIV incidence on the East Coast.
Similar content being viewed by others
References
Holmberg SD. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am J Public Health. 1996;86:642–654.
Kral AH, Bluthenthal RN, Booth RE, Watters JK. HIV seroprevalence among street-recruited injection drug and crack cocaine users in 16 US municipalities. Am J Public Health. 1998;88:108–112.
Monterroso ER, Hamburger ME, Vlahov D, et al. Prevention of HIV infection in street-recruited injection drug users. J Acquir Immune Defic Syndr Human Retrovirol. 2000;25:63–70.
Watters JK, Biernacki P. Targeted sampling: options for the study of hidden populations. Soc Problems. 1989;36:416–430.
Biernacki P, Waldorf D. Snowball sampling: problems and techniques in chain-referral sampling. Soc Methods Res. 1981;10:141–163.
Des Jarlais DC, Friedman SR, Novick DM, et al. HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987. JAMA. 1989; 261:1008–1012.
Neaigus A, Friedman SR, Jose B, et al. High-risk personal networks and syringe sharing as risk factors for HIV infection among new drug injectors. J Acquir Immune Defic Syndr Human Retrovirol. 1996;11:499–509.
Byers RH Jr, Morgan M, Darrow WW, et al. Estimating AIDS infection rates in the San Francisco Cohort. AIDS. 1988;2:207–10.
Winkelstein WW Jr, Samuel M, Padian NS, et al. The San Francisco Men’s Health Study: III. Reduction in human immunodeficiency virus transmission among homosexual/bisexual men, 1982–6. Am J Public Health. 1987;77:685–689.
Weniger BG, Limpakrnjanarat K, Ungchusak K, et al. The epidemiology of HIV infection and AIDS in Thailand. AIDS. 1991;5(suppl 2):S71-S76.
Jain MK, John JT, Keusch GT. Epidemiology of HIV and AIDS in India. AIDS. 1994;8(suppl 2):S61-S67.
Clatts MC, Heimer R, Abdala N, et al. HIV-1 transmission in injection paraphernalia: heating drug solutions may inactivate HIV-1 J Acquir Immune Defic Syndr Human Retrovirol. 1999;22:194–199.
Murrill CS, Weeks H, Castrucci BC, et al. Age-specific seroprevalence of HIV, hepatitis B virus and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities. Am J Public Health. 2002;92:385–387.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Garfein, R.S., Monterroso, E.R., Tong, T.C. et al. Comparison of HIV infection risk behaviors among injection drug users from East and West Coast US cities. J Urban Health 81, 260–267 (2004). https://doi.org/10.1093/jurban/jth112
Issue Date:
DOI: https://doi.org/10.1093/jurban/jth112